Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-12

Clinical Trial Update: Histological Improvement of NASH With Prebiotic [NA]

View source ↗

Summary

A completed clinical trial investigated histological improvement in non-alcoholic fatty liver disease (NASH) using a prebiotic therapy, suggesting potential ben…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prebiotic therapy (Prebiotic)

Snippet

Sponsor: University of Calgary | Conditions: Non-Alcoholic Fatty Liver Disease | NA | Status: COMPLETED